Peptides effective in the treatment of tumors and other...

Details Peptides effective in the treatment of tumors and other... Peptides effective in the treatment of tumors and other...

2007-07-10

2007-07-10

Foley, Shanon (Department: 1642)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S300000, C530S324000, C530S326000, C530S327000

Reexamination Certificate

active

10198070

ABSTRACT:
The present invention relates to peptides, compositions, and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such proteins), the amino acid sequence of which includes at least one amino acid sequence derived from neural thread proteins and other related molecules.

REFERENCES:
patent: 5830670 (1998-11-01), de la Monte et al.
patent: 5948634 (1999-09-01), de la Monte et al.
patent: 5948888 (1999-09-01), de la Monte et al.
patent: 6071705 (2000-06-01), Wands et al.
patent: WO 0200718 (2002-01-01), None
patent: WO 02070539 (2002-01-01), None
patent: WO 02 097030 (2002-12-01), None
Burgess et al. (J. Cell Biol. 111:2129-2138, 1990).
Lazar et al. ( Mol. Cell Biol. 8:1247-1252, 1998).
Wen et al. (Proc. Natl. Acad. Sci. U.S.A. 98: 4622-4627, 2001).
Brady et al. (Nature 1994; 368, 692-693).
Bork (2000) “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle.” Genome Research 10:398-400.
Skolnick and Fetrow (2000) “From gene to protein structure and function: novel applications of computational approaches in the genomic era.” Trends in Biotech. 18(1): 34-39.
Doerks et al., (Jun. 1998) “Protein annotation: detective work for function prediction.” Trends in Genetics 14(6): 248-250.
Smith and Zhang (Nov. 1997) “The challenges of genome sequence annotation or ‘The devil is in the details’.” Nature Biotechnology 15:1222-1223.
Bork and Bairoch (Oct. 1996) “Go hunting in sequence databases but watch out for the traps.” Trends in Genetics 12(10): 425-427.
Nair et al. (J. Immunol. 2003; 170: 1362-73).
Okada et al. (J. Biol. Chem. 1999; 274: 27359-27370).
Sijts et al.: “Immunodominant Mink Cell Focus-Inducing Murine Leukemia Virus(MuLV)-Encoded CTL Epitope, Identified by its MHC Class I-Binding Motif, Explains MuLV-Type Specificity of MCF-Directed Cytotoxic T. Lymphocytes” Journal of Immunology, vol. 152, 1994, pp. 106-116.
Feltkamp et al.: “Efficient MHC Class I-Peptide Binding Is Required Bu Does Not Ensure MHC Class I-Restricted Immunogenicity”Molecular Immunology, vol. 31, No. 18, Dec. 1994, pp. 1391-1401.
International Search Report issued in PCT/CA02/01106 dated of mailing Sep. 11, 2003.
Nair et al. “Mimicry of native peptide antigens by the corresponding retro-inverso analogs is dependent on their intrinsic structure and interaction propensities”J Immunol. Feb. 1, 2003;170(3):1362-73.

Affiliated with

Also associated with

Rating

Peptides effective in the treatment of tumors and other... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides effective in the treatment of tumors and other..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides effective in the treatment of tumors and other... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3735702